.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,753,677

« Back to Dashboard

Claims for Patent: 5,753,677

Title: Benzoheterocyclic compounds
Abstract:Novel benzoheterocyclic compounds of the formula: ##STR1## which have excellent vasopressin antagonistic activities and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.
Inventor(s): Ogawa; Hidenori (Tokushima-ken, JP), Miyamoto; Hisashi (Kyoto-fu, JP), Kondo; Kazumi (Tokushima-ken, JP), Yamashita; Hiroshi (Tokushima-ken, JP), Nakaya; Kenji (Tokushima-ken, JP), Komatsu; Hajime (Tokushima-ken, JP), Tanaka; Michinori (Tokushima-ken, JP), Kora; Shinya (Nagasaki-ken, JP), Tominaga; Michiaki (Tokushima-ken, JP), Yabuuchi; Yoichi (Tokushima-ken, JP)
Assignee: Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:08/474,544
Patent Claims: 1. A method for antagonizing vasopressin which comprises administering to a subject a therapeutically effective amount of a benzoheterocyclic compound of the formula: ##STR3330## wherein R.sup.1 is a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.6 alkyl, an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkoxy,

R.sup.2 is a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.6 alkoxy, a phenyl-(C.sub.1 -C.sub.6) alkoxy, hydroxy, a C.sub.1 -C.sub.6 alkyl, an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a carbamoyl-substituted C.sub.1 -C.sub.6 alkoxy, an amino-substituted C.sub.1 -C.sub.6 alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a benzoyloxy which has optionally a halogen substituent on the phenyl ring,

R.sup.3 is a group of the formula: ##STR3331## or a group of the formula: ##STR3332## R.sup.4 is a hydrogen atom, a benzoyl which has optionally a halogen substituent on the phenyl ring or a C.sub.1 -C.sub.6 alkyl,

R.sup.5 is a group of the formula: ##STR3333## wherein R.sup.16 is a halogen atom; a C.sub.1 -C.sub.6 alkyl which has optionally a substituent selected from a halogen atom and hydroxy; hydroxy; a C.sub.1 -C.sub.6 alkoxy; a C.sub.1 -C.sub.6 alkanoyloxy; a C.sub.1 -C.sub.6 alkylthio; a C.sub.1 -C.sub.6 alkanoyl; carboxy; a C.sub.1 -C.sub.6 alkoxycarbonyl; cyano; nitro; an amino which has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl; phenyl; a C.sub.3 -C.sub.8 cycloalkyl; a C.sub.2 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkoxy; a carboxy-substituted C.sub.1 -C.sub.6 alkoxy; a halogen-substituted C.sub.1 -C.sub.6 alkoxy; a carbamoyl-substituted C.sub.1 -C.sub.6 alkoxy; a hydroxy-substituted C.sub.1 -C.sub.6 alkoxy; a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkoxy; a phthalimido-substituted C.sub.1 -C.sub.6 alkoxy; an aminocarbonyl-(C.sub.1 -C.sub.6) alkoxy having a C.sub.1 -C.sub.6 alkyl substituent; or a group of the formula: ##STR3334## wherein A is a C.sub.1 -C.sub.6 alkylene, and R.sup.6 and R.sup.7 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.1 -C.sub.6 alkanoyl, or benzoyl, or R.sup.6 and R.sup.7 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from piperidinyl and a C.sub.1 -C.sub.6 alkyl; and m is an integer of 0 to 3, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3335## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3336## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl,

R.sup.11 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl,

R.sup.12 is a C.sub.3 -C.sub.8 cycloalkyl, or a phenyl which has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkoxy, a C.sub.1 -C.sub.6 alkyl and a halogen atom,

W is a group of the formula: --(CH.sub.2).sub.p -- wherein p is an integer of 3 to 5, or a group of the formula: --CH.dbd.CH--(CH.sub.2).sub.q -- wherein q is an integer of 1 to 3, and further said --(CH.sub.2).sub.p -- group and said --CH.dbd.CH--(CH.sub.2).sub.q -- group having optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.1 -C.sub.6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C.sub.1 -C.sub.6 alkanoyloxy having optionally a halogen substituent, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkylsulfonyloxy-(C.sub.1 -C.sub.6) alkyl, an azido-(C.sub.1 -C.sub.6) alkyl, a group of the formula: ##STR3337## an aminocarbonyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a C.sub.1 -C.sub.6 alkoxy, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkoxy, a carboxy-substituted C.sub.1 -C.sub.6 alkoxy, an aminocarbonyl-(C.sub.1 -C.sub.6) alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, an amino-(C.sub.1 -C.sub.6) alkoxy having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a phthalimido-substituted C.sub.1 -C.sub.6 alkoxy, hydroxy-imino, a C.sub.1 -C.sub.6 alkanoyloxy-imino, a C.sub.1 -C.sub.6 alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: ##STR3338## wherein R.sup.81 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl, hydrazino, pyrrolyl, an amino-(C.sub.2 -C.sub.6) alkanoyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a group of the formula: ##STR3339## wherein A is as defined above in this claim, and R.sup.82 and R.sup.83 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a hydroxy-substituted C.sub.1 -C.sub.6 alkyl, or a pyridyl-(C.sub.1 -C.sub.6) alkyl, or R.sup.82 and R.sup.83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3340## wherein n is as defined above in this claim, and R.sup.14 and R.sup.15 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a C.sub.2 -C.sub.6 alkenyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl, an oxiranyl-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkyl having 1 to 2 substituents selected from a C.sub.1 -C.sub.6 alkoxy, hydroxy and an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a phenyl-(C.sub.1 -C.sub.6) alkyl, a pyridyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkylsulfonyl, benzoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, a cyano-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a carboxy-substituted C.sub.1 -C.sub.6 alkyl, a tetrahydropyranyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a piperidinyl having optionally a phenyl-(C.sub.1 -C.sub.6) alkyl substituent on the piperidine ring, a halogen substituted C.sub.1 -C.sub.6 alkanoyl, an imidazolyl-substituted C.sub.2 -C.sub.6 alkanoyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkoxycarbonyl, an aminocarbonyl-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, or R.sup.14 or R.sup.15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl or a C.sub.1 -C.sub.6 alkanoyl, and a pharmaceutically acceptable salt thereof.

2. The method according to claim 1, wherein R.sup.1 is a hydrogen atom.

3. The method according to claim 1, wherein R.sup.1 is a halogen atom.

4. The method according to claim 1, wherein R.sup.1 is a C.sub.1 -C.sub.6 alkyl, an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkoxy.

5. The method according to claim 2, wherein R.sup.2 is a hydrogen atom.

6. The method according to claim 2, wherein R.sup.2 is a halogen atom, a C.sub.1 -C.sub.6 alkoxy, or a C.sub.1 -C.sub.6 alkyl.

7. The method according to claim 2, wherein R.sup.2 is a phenyl-(C.sub.1 -C.sub.6) alkoxy, hydroxy, an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a carbamoyl-substituted C.sub.1 -C.sub.6 alkoxy, an amino-substituted C.sub.1 -C.sub.6 alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a benzoyloxy having optionally a halogen substituent on the phenyl ring.

8. The method according to claim 3, wherein R.sup.2 is a hydrogen atom.

9. The method according to claim 3, wherein R.sup.2 is a halogen atom, a C.sub.1 -C.sub.6 alkoxy, or a C.sub.1 -C.sub.6 alkyl.

10. The method according to claim 3, wherein R.sup.2 is a phenyl-(C.sub.1 -C.sub.6) alkoxy, hydroxy, an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a carbamoyl-substituted C.sub.1 -C.sub.6 alkoxy, an amino-substituted C.sub.1 -C.sub.6 alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a benzoyloxy having optionally a halogen substituent on the phenyl ring.

11. The method according to claim 4, wherein R.sup.2 is a hydrogen atom.

12. The method according to claim 4, wherein R.sup.2 is a halogen atom, a C.sub.1 -C.sub.6 alkoxy, or a C.sub.1 -C.sub.6 alkyl.

13. The method according to claim 4, wherein R.sup.2 is a phenyl-(C.sub.1 -C.sub.6) alkoxy, hydroxy, an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a carbamoyl-substituted C.sub.1 -C.sub.6 alkoxy, an amino-substituted C.sub.1 -C.sub.6 alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a benzoyloxy having optionally a halogen substituent on the phenyl ring.

14. The method according to claim 5, wherein R.sup.3 is a group of the formula: ##STR3341## wherein R.sup.4 and R.sup.5 are as defined in claim 1.

15. The method according to claim 5, wherein R.sup.3 is a group of the formula: ##STR3342## wherein R.sup.11 and R.sup.12 are as defined in claim 1.

16. The method according to claim 6, wherein R.sup.3 is a group of the formula: ##STR3343## wherein R.sup.4 and R.sup.5 are as defined in claim 1.

17. The method according to claim 6, wherein R.sup.3 is a group of the formula: ##STR3344## wherein R.sup.11 and R.sup.12 are as defined in claim 1.

18. The method according to claim 8, wherein R.sup.3 is a group of the formula: ##STR3345## wherein R.sup.4 and R.sup.5 are as defined in claim 1.

19. The method according to claim 8, wherein R.sup.3 is a group of the formula: ##STR3346## wherein R.sup.11 and R.sup.12 are as defined in claim 1.

20. The method according to claim 9, wherein R.sup.3 is a group of the formula: ##STR3347## wherein R.sup.4 and R.sup.5 are as defined in claim 1.

21. The method according to claim 9, wherein R.sup.3 is a group of the formula: ##STR3348## wherein R.sup.11 and R.sup.12 are as defined in claim 1.

22. The method according to claim 14, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3349## and R.sup.16 and m are as defined in claim 1.

23. The method according to claim 14, wherein R.sup.4 is a hydrogen atom and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3350## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6)alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3351## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

24. The method according to claim 14, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

25. The method according to claim 16, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3352## wherein R.sup.16 and m are as defined in claim 1.

26. The method according to claim 16, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3353## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3354## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

27. The method according to claim 16, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

28. The method according to claim 7, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3355## wherein R.sup.16 and m are as defined in claim 1.

29. The method according to claim 7, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3356## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3357## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

30. The method according to claim 7, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

31. The method according to claim 18, wherein R.sup.4 is a hydrogen atom, R.sup.5 is a group of the formula: ##STR3358## wherein R.sup.16 and m are as defined in claim 1.

32. The method according to claim 18, wherein R.sup.4 is hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted (C.sub.1 -C.sub.6) alkanoyl, a group of the formula: ##STR3359## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl), an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3360## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

33. The method according to claim 18, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

34. The method according to claim 20, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3361## wherein R.sup.16 and m are as defined in claim 1.

35. The method according to claim 20, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3362## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.1 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3363## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 C.sub.6 alkoxycarbonyl and piperidinyl.

36. The method according to claim 20, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

37. The method according to claim 10, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3364## wherein R.sup.16 and m are as defined in claim 1.

38. The method according to claim 10, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3365## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3366## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

39. The method according to claim 10, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

40. The method according to claim 11, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3367## wherein R.sup.16 and m are as defined in claim 1.

41. The method according to claim 11, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3368## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3369## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.2 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

42. The method according to claim 12, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

43. The method according to claim 12, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3370## wherein R.sup.16 and m are as defined in claim 1.

44. The method according to claim 12, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl,naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3371## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3372## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

45. The method according to claim 12, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

46. The method according to claim 13, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a group of the formula: ##STR3373## wherein R.sup.16 and m are as defined in claim 1.

47. The method according to claim 13, wherein R.sup.4 is a hydrogen atom, and R.sup.5 is a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a C.sub.1 -C.sub.6 alkanoyl, a phenyl(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl-(C.sub.2 -C.sub.6) alkanoyl, a C.sub.3 -C.sub.8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C.sub.2 -C.sub.6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and an amino having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a phthalimido-substituted C.sub.2 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-(C.sub.2 -C.sub.6) alkanoyl, a carboxy-(C.sub.2 -C.sub.6) alkanoyl, a naphthyloxy-(C.sub.2 -C.sub.6) alkanoyl, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, a group of the formula: ##STR3374## wherein R.sup.8 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, a carbamoyl-(C.sub.1 -C.sub.6) alkyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a C.sub.1 -C.sub.6 alkanoyl, an anilinocarbonyl which has optionally a C.sub.1 -C.sub.6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C.sub.1 -C.sub.6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3375## wherein B is a C.sub.1 -C.sub.6 alkylene, n is an integer of 0 or 1, and R.sup.9 and R.sup.10 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.3 -C.sub.8 cycloalkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.2 -C.sub.6 alkenyl, a phenoxy-(C.sub.1 -C.sub.6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy and a halogen atom, a phthalimido-substituted C.sub.1 -C.sub.6 alkyl, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkanoyl substituent, a C.sub.2 -C.sub.6 alkynyl, or an amino-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or R.sup.9 and R.sup.10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl and piperidinyl.

48. The method according to claim 13, wherein R.sup.4 is a C.sub.1 -C.sub.6 alkyl.

49. The method according to claim 22, wherein R.sup.16 is a halogen atom, or a C.sub.1 -C.sub.6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

50. The method according to claim 25, wherein R.sup.16 is a halogen atom, or a C.sub.1 -C.sub.6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

51. The method according to claim 31, wherein R.sup.16 is a halogen atom, or a C.sub.1 -C.sub.6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

52. The method according to claim 34, wherein R.sup.16 is a halogen atom, or a C.sub.1 -C.sub.6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

53. The method according to claim 1, wherein W is a group of the formula: --(CH.sub.2).sub.p -- wherein p is an integer of 3 to 5, and further said --(CH.sub.2).sub.p -- group has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.1 -C.sub.6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C.sub.1 -C.sub.6 alkanoyloxy having optionally a halogen substituent, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkylsulfonyloxy-(C.sub.1 -C.sub.6) alkyl, an azido-(C.sub.1 -C.sub.6) alkyl, a group of the formula: ##STR3376## an aminocarbonyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a C.sub.1 -C.sub.6 alkoxy, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkoxy, a carboxy-substituted C-C.sub.6 alkoxy, an amino-carbonyl-(C.sub.1 -C.sub.6) alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, an amino-(C.sub.1 -C.sub.6) alkoxy having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a phthalimido-substituted C.sub.1 -C.sub.6 alkoxy, hydroxyimino, a C.sub.1 -C.sub.6 alkanoyloxy-imino, a C.sub.1 -C.sub.6 alkylidene, a halogen atom, azido, sulfoxy-imino, a group of the formula: ##STR3377## wherein R.sup.81 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl, hydrazino, pyrrolyl, an amino-(C.sub.2 -C.sub.6) alkanoyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a group of the formula: ##STR3378## wherein A is as defined above, and R.sup.82 and R.sub.83 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a hydroxy-substituted C.sub.1 -C.sub.6 alkyl, or a pyridyl-(C.sub.1 -C.sub.6) alkyl, or R.sup.82 and R.sup.83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3379## wherein n is as defined above, and R.sup.14 and R.sup.15 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a C.sub.2 -C.sub.6 alkenyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl, an oxiranyl-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkyl having 1 to 2 substituents selected from a C.sub.1 -C.sub.6 alkoxy, hydroxy and an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a phenyl-(C.sub.1 -C.sub.6) alkyl, a pyridyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkylsulfonyl, benzoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, a cyano-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a carboxy-substituted C.sub.1 -C.sub.6 alkyl, a tetrahydropyranyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a piperidinyl having optionally a phenyl-(C.sub.1 -C.sub.6) alkyl substituent on the piperidine ring, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, an imidazolyl-substituted C.sub.2 -C.sub.6 alkanoyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkoxycarbonyl, an aminocarbonyl-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, or R.sup.14 or R.sup.15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl or a C.sub.1 -C.sub.6 alkanoyl.

54. The method according to claim 1, wherein W is a group of the formula: --CH.dbd.CH--(CH.sub.2).sub.q -- wherein q is an integer of 1 to 3, and further said --CH.dbd.CH--(CH.sub.2).sub.q -- group has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.1 -C.sub.6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C.sub.1 -C.sub.6 alkanoyloxy having optionally a halogen substituent, an amino-(C.sub.1 -C.sub.6) alkyl having optionally substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkylsulfonyloxy -(C.sub.1 -C.sub.6) alkyl, an azido --(C.sub.1 -C.sub.6) alkyl, a group of the formula: ##STR3380## an aminocarbonyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a C.sub.1 -C.sub.6 alkoxy, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkoxy, a carboxy-substituted C.sub.1 -C.sub.6 alkoxy, an aminocarbonyl-(C.sub.1 -C.sub.6) alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, an amino-(C.sub.1 -C.sub.6) alkoxy having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a phthalimido-substituted C.sub.1 -C.sub.6 alkoxy, hydroxyimino, a C.sub.1 -C.sub.6 alkanoyloxy-imino, a C.sub.1 -C.sub.6 alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: ##STR3381## wherein R.sup.18 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl, hydrazino, pyrrolyl, an amino-(C.sub.2 -C.sub.6) alkanoyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a group of the formula: ##STR3382## wherein A is as defined above, and R.sup.82 and R.sup.83 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a hydroxy-substituted C.sub.1 -C.sub.6 alkyl, or a pyridyl-(C.sub.1 -C.sub.6) alkyl, or R.sup.82 and R.sup.83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3383## wherein n is as defined above, and R.sup.14 and R.sup.15 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a C.sub.2 -C.sub.6 alkenyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl, an oxiranyl-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkyl having 1 to 2 substituents selected from a C.sub.1 -C.sub.6 alkoxy, hydroxy and an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a phenyl-(C.sub.1 -C.sub.6) alkyl, a pyridyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkylsulfonyl, benzoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, a cyano-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a carboxy-substituted C.sub.1 -C.sub.6 alkyl, a tetrahydropyranyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a piperidinyl having optionally a phenyl-(C.sub.1 -C.sub.6) alkyl substituent on the piperidine ring, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, an imidazolyl-substituted C.sub.2 -C.sub.6 alkanoyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkoxycarbonyl, an aminocarbonyl-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, or R.sup.14 or R.sup.15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen atom or an oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl or a C.sub.1 -C.sub.6 alkanoyl.

55. The method according to claim 53, wherein W is a group of the formula: --(CH.sub.2).sub.p -- wherein p is an integer of 3 to 5, and said --(CH.sub.2).sub.p -- group has optionally 1 to 3 substituents selected from a C.sub.1 -C.sub.6 alkyl having optionally a hydroxy substituent, a C.sub.1 -C.sub.6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C.sub.1 -C.sub.6 alkanoyloxy having optionally a halogen substituent, an amino-(C.sub.1 -C.sub.6) alkyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkylsulfonyloxy-(C.sub.1 -C.sub.6) alkyl, an azido -(C.sub.1 -C.sub.6) alkyl, a group of the formula: ##STR3384## an aminocarbonyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a C.sub.1 -C.sub.6 alkoxy, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkoxy, a carboxy-substituted C.sub.1 -C.sub.6 alkoxy, an aminocarbonyl-(C.sub.1 -C.sub.6) alkoxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, an amino-(C.sub.1 -C.sub.6) alkoxy having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkanoyl, a phthalimido-substituted C.sub.1 -C.sub.6 alkoxy, hydroxyimino, a C.sub.1 -C.sub.6 alkanoyloxyimino, a C.sub.1 -C.sub.6 alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: ##STR3385## wherein R.sup.81 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl, hydrazino, pyrrolyl, an amino-(C.sub.2 -C.sub.6) alkanoyloxy having optionally a C.sub.1 -C.sub.6 alkyl substituent, a group of the formula: ##STR3386## wherein A is as defined above, and R.sup.82 and R.sup.83 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a hydroxy-substituted C.sub.1 -C.sub.6 alkyl, or a pyridyl-(C.sub.1 -C.sub.6) alkyl, or R.sup.82 and R.sup.83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3387## wherein n is as defined above, and R.sup.14 and R.sup.15 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, a C.sub.2 -C.sub.6 alkenyl, a C.sub.1 -C.sub.6 alkanoyl, a C.sub.3 -C.sub.8 cycloalkyl, an oxiranyl-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkyl having 1 to 2 substituents selected from a C.sub.1 -C.sub.6 alkoxy, hydroxy and an amino having optionally a C.sub.1 -C.sub.6 alkyl substituent, a phenyl-(C.sub.1 -C.sub.6) alkyl, a pyridyl-(C.sub.1 -C.sub.6) alkyl, a C.sub.1 -C.sub.6 alkylsulfonyl, benzoyl, a C.sub.1 -C.sub.6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, a cyano-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxycarbonyl-substituted C.sub.1 -C.sub.6 alkyl, a carbamoyl-substituted C.sub.1 -C.sub.6 alkyl, a carboxy-substituted C.sub.1 -C.sub.6 alkyl, a tetrahydropyranyloxy-substituted C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkanoyloxy-substituted C.sub.1 -C.sub.6 alkyl, a piperidinyl having optionally a phenyl-(C.sub.1 -C.sub.6) alkyl substituent on the piperidine ring, a halogen-substituted C.sub.1 -C.sub.6 alkanoyl, an imidazolyl-substituted C.sub.2 -C.sub.6 alkanoyl, an amino-(C.sub.2 -C.sub.6) alkanoyl having optionally a substituent selected from a C.sub.1 -C.sub.6 alkyl and a C.sub.1 -C.sub.6 alkoxycarbonyl, an aminocarbonyl-(C.sub.1 -C.sub.6) alkyl having optionally a C.sub.1 -C.sub.6 alkyl substituent, or a phenyl-(C.sub.1 -C.sub.6) alkoxycarbonyl, or R.sup.14 or R.sup.15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C.sub.1 -C.sub.6 alkyl, a phenyl-(C.sub.1 -C.sub.6) alkyl or a C.sub.1 -C.sub.6 alkanoyl.

56. The method according to claim 55, wherein p in the group of the formula: --(CH.sub.2).sub.p -- is 3 and the group has no substituent.

57. The method according to claim 55, wherein p in the group of the formula: --(CH.sub.2).sub.p -- is 3 and the group has a substituent of group of the formula: ##STR3388##

58. The method according to claim 55, wherein p in the group of the formula: --(CH.sub.2).sub.p -- is 4 and the group has no substituent.

59. The method according to claim 55, wherein p in the group of the formula: --(CH.sub.2).sub.p -- is 4 and the group has a substituent of a group of the formula: ##STR3389## wherein R.sup.14 and R.sup.15 and n are as defined in claim 55.

60. The method according to claim 55, wherein p in the group of the formula: --(CH.sub.2).sub.p -- is 5.

61. The method according to claim 54, wherein q in the group of the formula: --CH.dbd.CH--(CH.sub.2).sub.q -- is 1.

62. The method according to claim 54, wherein q in the group of the formula: --CH.dbd.CH--(CH.sub.2).sub.q -- is 2.

63. The method according to claim 54, wherein q in the group of the formula: --CH.dbd.CH--(CH.sub.2).sub.q -- is 3.

64. The method according to claim 57 or 59, wherein n in the group of the formula: ##STR3390## is 0, and R.sup.14 and R.sup.15 are the same or different and are each a hydrogen atom, a C.sub.1 -C.sub.6 alkyl, or a C.sub.3 -C.sub.8 cycloalkyl.

65. The method according to claim 62, wherein the heterocyclic group of the formula: ##STR3391## is 2,3,-dihydro-1 H-benzazepine.

66. The method according to claim 1, wherein the benzoheterocyclic compound is 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine.

67. The method according to claim 1, wherein the benzoheterocyclic compound is 5-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetra hydro-1H-benzazepine.

68. The method according to claim 1, wherein the benzoheterocyclic compound is 5-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahy dro-1H-benzazepine.

69. The method according to claim 1, wherein the benzoheterocyclic compound is 5-cyclopropylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-te trahydro-1H-benzazepine.

70. The method according to claim 1, wherein the benzoheterocyclic compound is 5-cyclopropylamino-1-[2-chloro-4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-te trahydro-1H-benzazepine.

71. The method according to claim 1, wherein the benzoheterocyclic compound is 5-dimethylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetra hydro-1H-benzazepine.

72. The method according to claim 1, wherein the benzoheterocyclic compound is 4-dimethylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetr ahydroquinoline.

73. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahy dro-1H-benzazepine.

74. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-methylamino-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahy dro-1H-benzazepine.

75. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-t etrahydro-1H-benzazepine.

76. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-hydroxy-1-[2-methoxy-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine.

77. The method according to claim 1, wherein the benzoheterocyclic compound is 7-fluoro-5-hydroxy-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-te trahydro-1H-benzazepine.

78. The method according to claim 1, wherein the benzoheterocyclic compound is 7-fluoro-5-hydroxymethyl-5-hydroxy-1-[2-chloro-4-(2-methylbenzoylamino)ben zoyl]-2,3,4,5-tetrahydro-1H-benzazepine.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc